ResearcherSun Yat-sen UniversityActive in the last 2 years
Wenbo Zhu
Matched on ORCID iD 0000-0001-5938-991X; OpenAlex author ID A5101639272. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 3
- Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study. Co-author DOI 10.20892/j.issn.2095-3941.2024.0036↗
- Selective extended dissection for pancreaticoduodenectomy is associated with better survival in pancreatic cancer patients: retrospective cohort study. Co-author DOI 10.1097/js9.0000000000000437↗
- Triptolide cooperates with Cisplatin to induce apoptosis in gemcitabine-resistant pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e31824abdc0↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaofan Guo · 2 shared papers, 2023–2024 · strength 0.40
- Paper Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study. DOI 10.20892/j.issn.2095-3941.2024.0036↗
- Paper Selective extended dissection for pancreaticoduodenectomy is associated with better survival in pancreatic cancer patie… DOI 10.1097/js9.0000000000000437↗
- Jihui Hao · 2 shared papers, 2023–2024 · strength 0.40
- Paper Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study. DOI 10.20892/j.issn.2095-3941.2024.0036↗
- Paper Selective extended dissection for pancreaticoduodenectomy is associated with better survival in pancreatic cancer patie… DOI 10.1097/js9.0000000000000437↗
- Xingyun Chen · 1 shared paper, 2024 · strength 0.22
- Jing Huang · 1 shared paper, 2024 · strength 0.22
- Yuxiao Liu · 1 shared paper, 2024 · strength 0.22
- Song Gao · 1 shared paper, 2024 · strength 0.22
- Chongbiao Huang · 1 shared paper, 2023 · strength 0.18
- Song Gao · 1 shared paper, 2023 · strength 0.18
- Yucheng Zhou · 1 shared paper, 2023 · strength 0.18
- Haiyan Hu · 1 shared paper, 2012 · strength 0.03
- Guangmei Yan · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.